SV2A and Alzheimer disease: To explore potential intermediary mechanisms linking gliosis with synaptic density in AD, we performed mediation analyses using AT8 (p-Tau), 4G8 (Ab17 − 24), GFAP, and P2X7R as candidate mediators and presynaptic markers (SV2A and SYP) as outcomes.